Subscribe to stay informed!
Devon-based Zynerba Pharmaceuticals has received “Fast Track” status from the FDA for its synthetic cannabidiol drug intended to treat symptoms associated with Fragile X…
Before we send you to this site, please subscribe to our daily newsletter.